Discontinued — last reported Q3 '25
Life Sciences — Depreciation and amortization of intangible assets
Danaher Life Sciences — Depreciation and amortization of intangible assets increased by 4.4% to $47.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.8%, from $44.00M to $47.00M. Over 3 years (FY 2021 to FY 2024), Life Sciences — Depreciation and amortization of intangible assets shows a downward trend with a -51.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase suggests higher capital intensity or recent acquisitions, while a decrease may indicate aging assets or reduced investment in intangible growth drivers.
Detailed definition
This metric represents the total non-cash expense recognized by the Life Sciences segment for the systematic allocation...
Peer comparison
Peers in the life sciences and diagnostics sector typically report this as part of their segment-level operating expenses, often correlated with the scale of their M&A activity.
dhr_segment_life_sciences_depreciation_and_amortization_of_intangible_assetsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $360.25M | $360.25M | $360.25M | $132.75M | $132.75M | $132.75M | $132.75M | $139.50M | $139.50M | $139.50M | $139.50M | $38.00M | $41.00M | $44.00M | $44.00M | $45.00M | $45.00M | $47.00M |
| QoQ Change | — | +0.0% | +0.0% | -63.2% | +0.0% | +0.0% | +0.0% | +5.1% | +0.0% | +0.0% | +0.0% | -72.8% | +7.9% | +7.3% | +0.0% | +2.3% | +0.0% | +4.4% |
| YoY Change | — | — | — | — | -63.2% | -63.2% | -63.2% | +5.1% | +5.1% | +5.1% | +5.1% | -72.8% | -70.6% | -68.5% | -68.5% | +18.4% | +9.8% | +6.8% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Danaher's life sciences — depreciation and amortization of intangible assets?
- Danaher (DHR) reported life sciences — depreciation and amortization of intangible assets of $47.00M in Q3 2025.
- How has Danaher's life sciences — depreciation and amortization of intangible assets changed year-over-year?
- Danaher's life sciences — depreciation and amortization of intangible assets increased by 6.8% year-over-year, from $44.00M to $47.00M.
- What is the long-term trend for Danaher's life sciences — depreciation and amortization of intangible assets?
- Over 3 years (2021 to 2024), Danaher's life sciences — depreciation and amortization of intangible assets has grown at a -51.2% compound annual growth rate (CAGR), from $1.44B to $167.00M.
- What does life sciences — depreciation and amortization of intangible assets mean?
- The total non-cash cost of using up physical equipment and intangible assets within the Life Sciences business segment.